Relmada Therapeutics Surges 6.3% to $3.36 Amid Peer Gains and Market Rally
Relmada Therapeutics shares jump 6.33% to $3.36, amid mixed peer gains and a 52‑week high of $8.00—explore why this mid‑cap pharma stock is gaining attention.
- RELMADA THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read